Genome & Co

314130

Company Profile

  • Business description

    Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

  • Contact

    Innovalley A-801
    Pangyo-ro 253, Bundang-gu
    Gyeonggi-do
    Seongnam-si13486
    KOR

    T: +82 316280150

    http://www.genomecom.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    92

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,374.0082.20-0.97%
CAC 407,727.9342.55-0.55%
DAX 4023,344.54257.891.12%
Dow JONES (US)41,218.8398.60-0.24%
FTSE 1008,596.3599.551.17%
HKSE22,504.68385.271.74%
NASDAQ17,844.24133.49-0.74%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,412.878.38-0.07%
S&P 5005,650.3836.29-0.64%
S&P/ASX 2008,157.8080.20-0.97%
SSE Composite Index3,279.037.62-0.23%

Market Movers